Both in Diagnostics
Alpha Teknova vs Intellia Therapeutics
Over the past year TKNO returned +44.9% and NTLA returned −4.6%; their daily moves had a correlation of 0.25.
TKNO +44.9% NTLA −4.6%Growth of $1, one year, split-adjusted
| Metric | TKNO | NTLA |
|---|---|---|
| Price | $7.36 | $12.47 |
| Market cap | $454.1M | $1.75B |
| Today | −9.02% | −5.74% |
| 1 month | −16.9% | +2.9% |
| 6 months | +116.5% | −6.0% |
| Year to date | +93.7% | +38.7% |
| 1 year | +36.8% | −5.0% |
| Revenue growth (YoY) | +18.5% | −46.2% |
| Gross margin | 40.1% | 100.0% |
| Net margin | −26.0% | −1392.3% |
| P/E (TTM) | — | — |
| Price / sales | 10.4× | 29.4× |
| Net cash | $4.2M | $437.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.4% | 62.1% |
| Short % of float | 19.5% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).